Skip to main content
Premium Trial:

Request an Annual Quote

Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement

NEW YORK – Resolution Bioscience said on Monday that it has signed a companion diagnostic agreement with San Diego-based Mirati Therapeutics.

As part of the collaboration, the firms will use Kirkland, Washington-based Resolution's ctDx liquid biopsy technology to help find non-small cell lung cancer (NSCLC) patients who may benefit from Mirati's investigational KRAS G12C inhibitor therapy.

Resolution's ctDx Lung Assay, which is covered by Medicare and private payors, applies next-generation sequencing to look for actionable mutations in cell-free DNA in a NSCLC patient's blood sample.

Mirati's adagrasib (MRTX849) is an orally available small molecule that selectively inhibits the G12C substitution mutation. The partners will use the ctDx Lung Assay to spot NSCLC patients whose cancer are driven by the G12C variant.

Financial details of the agreement were not disclosed.

"We are excited to join forces with Mirati to address this large unmet medical need and to further drive adoption of our innovative liquid biopsy diagnostic tests," Mark Li, CEO of Resolution Bioscience, said in a statement. "Our mission is to provide critical [and] actionable information to improve care and clinical care outcomes for cancer patients worldwide."

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.